Afoxolaner for Scorpion: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Afoxolaner is a prescription parasite medication in the isoxazoline class. In the U.S., it is best known as the active ingredient in NexGard chewables for dogs. It works by affecting the nervous system of fleas and ticks, which kills those parasites after they bite.

This medication is approved for dogs, not scorpions. If your scorpion page exists because of a catalog or template mismatch, the safest takeaway is this: do not use afoxolaner in a scorpion unless your vet has given species-specific instructions. There is no standard companion-animal label dosing for pet scorpions, and safety data for arachnid pets are not established.

In dogs, afoxolaner is commonly given as a once-monthly oral chew. It may be used alone or as part of a combination product. Your vet may also discuss off-label use in certain mite cases, but that decision depends on the pet, the parasite involved, and the pet's neurologic history.

In dogs, afoxolaner is used to treat and prevent flea infestations and to treat and control several tick species for about one month per dose. Current U.S. labeling also includes prevention of Borrelia burgdorferi infection as a direct result of killing black-legged ticks before Lyme transmission occurs.

Your vet may also consider afoxolaner off-label for some mite problems, including certain mange cases, when that approach fits the pet's overall plan. Off-label use is common in veterinary medicine, but it should always be guided by your vet because the diagnosis, parasite species, and follow-up plan matter.

For a scorpion, there is no routine evidence-based use described on standard companion-animal labels. If you are dealing with mites, enclosure pests, or another health concern in an exotic pet, your vet may recommend a very different treatment strategy based on species safety, husbandry, and the exact parasite involved.

For dogs, labeled afoxolaner dosing is by body weight and given once every 30 days. Reference sources describe a recommended range of about 2.7-7 mg/kg orally, while the U.S. product labeling gives a minimum monthly dose of 2.5 mg/kg using weight-based chew sizes. Puppies generally must be at least 8 weeks old and at least 4 pounds before labeled use.

Afoxolaner can be given with or without food. Your vet will choose the correct chew size based on your pet's current weight. If a dog vomits within about 2 hours of dosing, veterinary references advise contacting your vet; many product instructions recommend giving another full dose if the first dose was vomited that quickly.

For a scorpion, there is no established standard dose that can be safely published for home use. Dosing in exotic species cannot be extrapolated from dogs or cats. If your scorpion has a suspected parasite issue, bring your pet and enclosure details to your vet so they can decide whether medication, environmental treatment, or supportive care is the safest option.

Most dogs tolerate afoxolaner well, but side effects can happen. Reported problems include vomiting, diarrhea, decreased appetite, lethargy, and dry or flaky skin. Mild stomach upset may pass, but ongoing signs deserve a call to your vet.

The most important caution with afoxolaner and other isoxazolines is the potential for neurologic adverse effects. The FDA has warned that pets in this drug class may experience muscle tremors, incoordination, or seizures, even in some pets without a prior seizure history. That does not mean every pet will have trouble, but it is an important risk-benefit discussion.

See your vet immediately if your pet develops tremors, stumbling, collapse, repeated vomiting, or seizures after a dose. If an accidental overdose or wrong-species exposure happens, treatment is usually supportive because there is no specific antidote for afoxolaner toxicosis.

Published veterinary references state that there are no documented drug interactions for afoxolaner. Even so, that does not mean every combination is risk-free for every pet. Your vet still needs a full list of prescription drugs, over-the-counter products, supplements, and herbal products before starting treatment.

The bigger practical concern is often patient selection, not a known direct interaction. Pets with a history of seizures, tremors, or other neurologic disease may need a different parasite-control plan. Your vet may also be more cautious in very young pets, breeding animals, or pets with multiple medical problems.

If your pet is already taking other monthly preventives, ask your vet whether you are duplicating parasite coverage or combining products in a way that changes the overall risk profile. That conversation is especially important for exotic pets, because published safety data are much thinner than they are for dogs.